KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Cash from Operations (2016 - 2025)

Teladoc Health's Cash from Operations history spans 12 years, with the latest figure at 87742000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 2.14% year-over-year to 87742000.0; the TTM value through Dec 2025 reached 294357000.0, changed 0.23%, while the annual FY2025 figure was 294357000.0, 0.23% changed from the prior year.
  • Cash from Operations for Q4 2025 was 87742000.0 at Teladoc Health, down from 99264000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 130082000.0 in Q4 2023 and bottomed at 31747000.0 in Q1 2022.
  • The 5-year median for Cash from Operations is 84555000.0 (2021), against an average of 66067000.0.
  • The largest YoY upside for Cash from Operations was 172.4% in 2021 against a maximum downside of 185.22% in 2021.
  • A 5-year view of Cash from Operations shows it stood at 83208000.0 in 2021, then fell by 21.22% to 65549000.0 in 2022, then surged by 98.45% to 130082000.0 in 2023, then plummeted by 33.96% to 85902000.0 in 2024, then increased by 2.14% to 87742000.0 in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Cash from Operations are 87742000.0 (Q4 2025), 99264000.0 (Q3 2025), and 91432000.0 (Q2 2025).